Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2008-02-29
2009-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Newly forming bone
Miller class I or II deep recessions treated by the newly forming bone technique.
Newly forming bone technique for root coverage
A granulation tissue will be obtained 21-25 days after the creation of an alveolar socket and grafted to receptor site.
Subepithelial connective tissue graft
Miller class I or II deep recessions treated by subepithelial connective tissue graft.
Subepithelial connective tissue graft for root coverage.
A subepithelial connective tissue graft will be used for the treatment of Miller class I or II deep recessions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Newly forming bone technique for root coverage
A granulation tissue will be obtained 21-25 days after the creation of an alveolar socket and grafted to receptor site.
Subepithelial connective tissue graft for root coverage.
A subepithelial connective tissue graft will be used for the treatment of Miller class I or II deep recessions.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnants
* Use of anti-convulsants, anti-hypertensives, cyclosporine or hormones
* Use of antibiotics for the last 6 months
* Patients under treatment for medical conditions or presenting systemic disorders that would impair treatment results (e.g.: uncontrolled diabetes mellitus)
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
OTHER_GOV
University of Sao Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Adriana Campos Passanezi SantAna
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adriana P Sant'Ana, DDS PhD
Role: PRINCIPAL_INVESTIGATOR
School of Dentistry at Bauru, University of São Paulo
Bruna R Ferraz, DDS
Role: PRINCIPAL_INVESTIGATOR
School of Dentistry at Bauru, University of São Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Dentistry at Bauru-USP, Discipline of Periodontics
Bauru, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
School of Dentistry at Bauru, University of São Paulo site information
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
115-2007
Identifier Type: -
Identifier Source: org_study_id